ROCHE HLDG LTD SPONS Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (26)

Latest Posts

About This Stock More About This Stock
Conatus Pharmaceuticals Launches Small Offering For Pipeline Expansion
Article By: Terry Chrisomalis
Friday, May 12, 2017 7:05 PM EDT
The offering doesn’t seem to make sense after the Novartis (NVS) licensing deal being signed.
In this article: CNAT, NVS, RHHBY
Read
Hologic Beats Q1 Sales And EPS
Article By: Rod Raynovich
Wednesday, May 10, 2017 10:28 PM EDT
Hologic's revenues Increased 3.2% and GAAP diluted Earnings Increased 666.7% Compared to Prior Year Period. The stock closed down 2% AH to $45.
In this article: RHHBY, HOLX, FMI
Read
Large Cap Biopharmaceutical Valuations: Q1 2017
Article By: Rod Raynovich
Monday, May 8, 2017 8:45 PM EDT
Large cap biopharmaceutical stocks are about 3-4% off their 2017 highs but have been losing momentum. Here is a quick review of the valuation metrics.
In this article: BMY, RHHBY, FBIOX, ALXN, IBB, REGN, AMGN, BIIB, CELG, GILD, FBT, XBI, ABBV
Read
E Global Earnings Update
Article By: Vivian Lewis
Thursday, April 27, 2017 6:45 PM EDT
Earnings and more for companies in Latin America and elsewhere, plus a focus on pharma.
In this article: CX, CZZ, GSK, NOK, PBR, VALE, VR, MXCHF, OROCF, RHHBF, RHHBY Also: AZSEY, SLFPY, FBASF, FMI, VRGDF
Read
18 Drugs To Lose Patents In 2017; Could Jeopardize $26.5B For Big Pharma
Article By: Lorimer Wilson
Saturday, April 22, 2017 8:24 PM EDT
With 18 branded drugs on the line, patent losses this year could jeopardize $26.5 billion in annual sales from Big Pharma, projected to be the biggest fall-off until at least 2025.
In this article: AZN, BMY, GSK, LLY, MRK, PFE, SNY, RHHBY, TEVA
Read

PARTNER HEADLINES

Latest Tweets for $RHHBY

No tweets yet!